JANX Competitors & Alternatives
Compare Janux Therapeutics Inc with similar stocks in the same industry
Biotechnology
JANX
Main Stock$13.76
Tradestie Score
58
Market Cap
$1.42B
Revenue Growth
21.8%
Analyst Upside
+194.8%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TNGX
Tango Therapeutics, Inc.
|
$21.09
|
$887.30M | - | 55 | Compare |
|
ABUS
Arbutus Biopharma Corporation Common Stock
|
$4.22
|
$879.90M | 5.1 | 52 | Compare |
|
PHAT
Phathom Pharmaceuticals, Inc. Common Stock
|
$11.89
|
$871.90M | - | 62 | Compare |
|
DNA
Ginkgo Bioworks Holdings, Inc.
|
$7.41
|
$868.46M | - | 52 | Compare |
|
TSHA
Taysha Gene Therapies, Inc. Common Stock
|
$5.84
|
$867.49M | - | 50 | Compare |
|
FTRE
Fortrea Holdings Inc. Common Stock
|
$13.90
|
$864.42M | - | 58 | Compare |
|
CRMD
CorMedix Inc.
|
$7.78
|
$862.55M | 3.9 | 56 | Compare |
|
SEPN
Septerna, Inc. Common Stock
|
$27.24
|
$847.12M | - | 59 | Compare |
|
XNCR
Xencor, Inc.
|
$11.12
|
$843.75M | - | 50 | Compare |
|
GHRS
GH Research PLC Ordinary Shares
|
$22.19
|
$841.74M | - | 60 | Compare |
More JANX Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry